Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Prior infection with SARS-CoV-2 boosts and broadens Ad26.COV2.S immunogenicity in a variant dependent manner

View ORCID ProfileRoanne Keeton, View ORCID ProfileSimone I. Richardson, View ORCID ProfileThandeka Moyo-Gwete, View ORCID ProfileTandile Hermanus, Marius B. Tincho, Ntombi Benede, Nelia P. Manamela, Richard Baguma, Zanele Makhado, Amkele Ngomti, Thopisang Motlou, Mathilda Mennen, Lionel Chinhoyi, Sango Skelem, Hazel Maboreke, Deelan Doolabh, Arash Iranzadeh, Ashley D. Otter, Tim Brooks, View ORCID ProfileMahdad Noursadeghi, James Moon, Jonathan Blackburn, Nei-Yuan Hsiao, Carolyn Williamson, Catherine Riou, Ameena Goga, Nigel Garrett, Linda-Gail Bekker, Glenda Gray, Ntobeko A. B. Ntusi, View ORCID ProfilePenny L. Moore, View ORCID ProfileWendy A. Burgers
doi: https://doi.org/10.1101/2021.07.24.21261037
Roanne Keeton
1Institute of Infectious Disease and Molecular Medicine; University of Cape Town; Observatory, South Africa
2Division of Medical Virology, Department of Pathology; University of Cape Town; Observatory, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Roanne Keeton
Simone I. Richardson
3National Institute for Communicable Diseases of the National Health Laboratory Services; Johannesburg, South Africa
4MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand; Johannesburg, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Simone I. Richardson
Thandeka Moyo-Gwete
3National Institute for Communicable Diseases of the National Health Laboratory Services; Johannesburg, South Africa
4MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand; Johannesburg, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Thandeka Moyo-Gwete
Tandile Hermanus
3National Institute for Communicable Diseases of the National Health Laboratory Services; Johannesburg, South Africa
4MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand; Johannesburg, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tandile Hermanus
Marius B. Tincho
1Institute of Infectious Disease and Molecular Medicine; University of Cape Town; Observatory, South Africa
2Division of Medical Virology, Department of Pathology; University of Cape Town; Observatory, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ntombi Benede
1Institute of Infectious Disease and Molecular Medicine; University of Cape Town; Observatory, South Africa
2Division of Medical Virology, Department of Pathology; University of Cape Town; Observatory, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nelia P. Manamela
3National Institute for Communicable Diseases of the National Health Laboratory Services; Johannesburg, South Africa
4MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand; Johannesburg, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard Baguma
1Institute of Infectious Disease and Molecular Medicine; University of Cape Town; Observatory, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zanele Makhado
3National Institute for Communicable Diseases of the National Health Laboratory Services; Johannesburg, South Africa
4MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand; Johannesburg, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amkele Ngomti
1Institute of Infectious Disease and Molecular Medicine; University of Cape Town; Observatory, South Africa
2Division of Medical Virology, Department of Pathology; University of Cape Town; Observatory, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thopisang Motlou
3National Institute for Communicable Diseases of the National Health Laboratory Services; Johannesburg, South Africa
4MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand; Johannesburg, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mathilda Mennen
5Department of Medicine, University of Cape Town and Groote Schuur Hospital; Observatory, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lionel Chinhoyi
5Department of Medicine, University of Cape Town and Groote Schuur Hospital; Observatory, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sango Skelem
5Department of Medicine, University of Cape Town and Groote Schuur Hospital; Observatory, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hazel Maboreke
1Institute of Infectious Disease and Molecular Medicine; University of Cape Town; Observatory, South Africa
6Division of Chemical and Systems Biology, Department of Integrative Biomedical Sciences, University of Cape Town, Cape Town, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Deelan Doolabh
1Institute of Infectious Disease and Molecular Medicine; University of Cape Town; Observatory, South Africa
2Division of Medical Virology, Department of Pathology; University of Cape Town; Observatory, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arash Iranzadeh
1Institute of Infectious Disease and Molecular Medicine; University of Cape Town; Observatory, South Africa
2Division of Medical Virology, Department of Pathology; University of Cape Town; Observatory, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ashley D. Otter
7National Infection Service, Public Health England, Porton Down, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tim Brooks
7National Infection Service, Public Health England, Porton Down, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mahdad Noursadeghi
8Division of Infection and Immunity, University College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mahdad Noursadeghi
James Moon
9Institute of Cardiovascular Sciences, University College London, London, UK
10Barts Heart Centre, St Bartholomew’s Hospital, Barts Health NHS Trust, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathan Blackburn
1Institute of Infectious Disease and Molecular Medicine; University of Cape Town; Observatory, South Africa
6Division of Chemical and Systems Biology, Department of Integrative Biomedical Sciences, University of Cape Town, Cape Town, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nei-Yuan Hsiao
2Division of Medical Virology, Department of Pathology; University of Cape Town; Observatory, South Africa
11NHLS Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carolyn Williamson
1Institute of Infectious Disease and Molecular Medicine; University of Cape Town; Observatory, South Africa
2Division of Medical Virology, Department of Pathology; University of Cape Town; Observatory, South Africa
12Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town; Observatory, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Catherine Riou
1Institute of Infectious Disease and Molecular Medicine; University of Cape Town; Observatory, South Africa
2Division of Medical Virology, Department of Pathology; University of Cape Town; Observatory, South Africa
12Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town; Observatory, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ameena Goga
13South African Medical Research Council, Cape Town, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nigel Garrett
14Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa
15Discipline of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Linda-Gail Bekker
1Institute of Infectious Disease and Molecular Medicine; University of Cape Town; Observatory, South Africa
16Desmond Tutu HIV Centre, Cape Town, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Glenda Gray
13South African Medical Research Council, Cape Town, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ntobeko A. B. Ntusi
1Institute of Infectious Disease and Molecular Medicine; University of Cape Town; Observatory, South Africa
5Department of Medicine, University of Cape Town and Groote Schuur Hospital; Observatory, South Africa
17Hatter Institute for Cardiovascular Research in Africa, Faculty of Health Sciences, University of Cape Town; Observatory, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: wendy.burgers@uct.ac.za pennym@nicd.ac.za ntobeko.ntusi@uct.ac.za
Penny L. Moore
3National Institute for Communicable Diseases of the National Health Laboratory Services; Johannesburg, South Africa
4MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand; Johannesburg, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Penny L. Moore
Wendy A. Burgers
1Institute of Infectious Disease and Molecular Medicine; University of Cape Town; Observatory, South Africa
2Division of Medical Virology, Department of Pathology; University of Cape Town; Observatory, South Africa
12Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town; Observatory, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Wendy A. Burgers
  • For correspondence: wendy.burgers@uct.ac.za pennym@nicd.ac.za ntobeko.ntusi@uct.ac.za
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Summary

The Johnson and Johnson Ad26.COV2.S single dose vaccine, designed as an emergency response to the pandemic, represents an attractive option for the scale-up of COVID-19 vaccination in resource-limited countries. We examined the effect of prior infection with ancestral (D614G) or Beta variants on Ad26.COV2.S immunogenicity approximately 28 days post-vaccination. We compared healthcare workers who were SARS-CoV-2 naive (n=20), to those infected during the first wave prior to the emergence of Beta (n=20), and those infected in the second wave (n=20), when Beta was the dominant variant. We demonstrate that a priming exposure from infection significantly increased the magnitude of spike binding antibodies, neutralizing antibodies and antibody-dependent cellular cytotoxicity activity (ADCC) against D614G, Beta and Delta variants. The magnitude of antibody boosting was similar in both waves, despite the longer time interval between wave 1 infection and vaccination (7 months), compared to wave 2 (2 months). ADCC and binding cross-reactivity was similar in both waves. However, neutralization cross-reactivity varied by wave, showing that the antibody repertoire was shaped by the spike sequence of the infecting variant. Robust CD4 and CD8 T cell responses to spike of similar or higher magnitude as those elicited by infection were induced after vaccination. In contrast to antibody responses, prior infection was not required for the generation of high magnitude T cell responses, and T cell recognition of the Beta variant was fully preserved. Therefore, Ad26.COV2.S vaccination following prior infection, even >6 months previously, may result in substantially enhanced protection against COVID-19, of particular relevance in settings of high SARS-CoV-2 seroprevalence. Furthermore, the dominant impact of the infecting variant on neutralization breadth after vaccination has important implications for the design of second-generation vaccines based on variants of concern.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Research reported in this publication was supported by the South African Medical Research Council (SA-MRC) with funds received from the South African Department of Science and Innovation, including grants 96825, SHIPNCD 76756 and DST/CON 0250/2012. This work was also supported by the Poliomyelitis Research Foundation (21/65) and the Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa), which is supported by core funding from the Wellcome Trust (203135/Z/16/Z and 222754). P.L.M. and S.I.R. are supported by the South African Research Chairs Initiative of the Department of Science and Innovation and the National Research Foundation (NRF; Grant No 9834). S.I.R. is a LOreal/UNESCO Women in Science South Africa Young Talents awardee. W.A.B. and C.R. are supported by the EDCTP2 programme of the European Unions Horizon 2020 programme (TMA2017SF-1951-TB-SPEC to C.R. and TMA2016SF-1535-CaTCH-22 to W.A.B.). N.A.B.N acknowledges funding from the SA-MRC, MRC UK, NRF and the Lily and Ernst Hausmann Trust. M.N. is supported by the Wellcome Trust (207511/Z/17/Z) and by NIHR Biomedical Research Funding to University College London Hospitals.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was approved by the University of Cape Town Human Research Ethics Committee (HREC 190/2020 and 209/2020) and the University of the Witwatersrand Human Research Ethics Committee (Medical) (no M210429).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data referred to in the manuscript is available in the manuscript or Supplementary files.

Data Availability

All data referred to in the manuscript is available in the manuscript or Supplementary files.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted July 28, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Prior infection with SARS-CoV-2 boosts and broadens Ad26.COV2.S immunogenicity in a variant dependent manner
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Prior infection with SARS-CoV-2 boosts and broadens Ad26.COV2.S immunogenicity in a variant dependent manner
Roanne Keeton, Simone I. Richardson, Thandeka Moyo-Gwete, Tandile Hermanus, Marius B. Tincho, Ntombi Benede, Nelia P. Manamela, Richard Baguma, Zanele Makhado, Amkele Ngomti, Thopisang Motlou, Mathilda Mennen, Lionel Chinhoyi, Sango Skelem, Hazel Maboreke, Deelan Doolabh, Arash Iranzadeh, Ashley D. Otter, Tim Brooks, Mahdad Noursadeghi, James Moon, Jonathan Blackburn, Nei-Yuan Hsiao, Carolyn Williamson, Catherine Riou, Ameena Goga, Nigel Garrett, Linda-Gail Bekker, Glenda Gray, Ntobeko A. B. Ntusi, Penny L. Moore, Wendy A. Burgers
medRxiv 2021.07.24.21261037; doi: https://doi.org/10.1101/2021.07.24.21261037
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Prior infection with SARS-CoV-2 boosts and broadens Ad26.COV2.S immunogenicity in a variant dependent manner
Roanne Keeton, Simone I. Richardson, Thandeka Moyo-Gwete, Tandile Hermanus, Marius B. Tincho, Ntombi Benede, Nelia P. Manamela, Richard Baguma, Zanele Makhado, Amkele Ngomti, Thopisang Motlou, Mathilda Mennen, Lionel Chinhoyi, Sango Skelem, Hazel Maboreke, Deelan Doolabh, Arash Iranzadeh, Ashley D. Otter, Tim Brooks, Mahdad Noursadeghi, James Moon, Jonathan Blackburn, Nei-Yuan Hsiao, Carolyn Williamson, Catherine Riou, Ameena Goga, Nigel Garrett, Linda-Gail Bekker, Glenda Gray, Ntobeko A. B. Ntusi, Penny L. Moore, Wendy A. Burgers
medRxiv 2021.07.24.21261037; doi: https://doi.org/10.1101/2021.07.24.21261037

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (180)
  • Allergy and Immunology (435)
  • Anesthesia (99)
  • Cardiovascular Medicine (949)
  • Dentistry and Oral Medicine (178)
  • Dermatology (111)
  • Emergency Medicine (260)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (423)
  • Epidemiology (9005)
  • Forensic Medicine (4)
  • Gastroenterology (421)
  • Genetic and Genomic Medicine (1962)
  • Geriatric Medicine (191)
  • Health Economics (405)
  • Health Informatics (1330)
  • Health Policy (662)
  • Health Systems and Quality Improvement (521)
  • Hematology (212)
  • HIV/AIDS (420)
  • Infectious Diseases (except HIV/AIDS) (10828)
  • Intensive Care and Critical Care Medicine (575)
  • Medical Education (200)
  • Medical Ethics (54)
  • Nephrology (223)
  • Neurology (1837)
  • Nursing (110)
  • Nutrition (274)
  • Obstetrics and Gynecology (357)
  • Occupational and Environmental Health (470)
  • Oncology (1004)
  • Ophthalmology (299)
  • Orthopedics (111)
  • Otolaryngology (183)
  • Pain Medicine (126)
  • Palliative Medicine (44)
  • Pathology (265)
  • Pediatrics (582)
  • Pharmacology and Therapeutics (276)
  • Primary Care Research (234)
  • Psychiatry and Clinical Psychology (1910)
  • Public and Global Health (4133)
  • Radiology and Imaging (676)
  • Rehabilitation Medicine and Physical Therapy (370)
  • Respiratory Medicine (551)
  • Rheumatology (226)
  • Sexual and Reproductive Health (191)
  • Sports Medicine (178)
  • Surgery (207)
  • Toxicology (39)
  • Transplantation (109)
  • Urology (82)